Date Filed | Type | Description |
06/16/2023 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 23,443 shares
@ $0 Granted 34,735 options to buy
@ $4.33, valued at
$150.4k
|
|
05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 9,945 shares
@ $0 Granted 29,640 options to buy
@ $7.33, valued at
$217.3k
|
|
05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/12/2022 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Converted 327,102 shares
@ $0 Converted 327,102 options to buy
@ $0 |
|
06/22/2021 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 15,000 options to buy
@ $33.74, valued at
$506.1k
|
|
06/21/2021 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Granted 14,846 options
@ $10.14, valued at
$150.5k
|
|
04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/11/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Granted 18,691 options to buy
@ $19, valued at
$355.1k
|
|
12/09/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Seer, Inc.
Txns:
| Converted 205,831 shares
@ $0 Converted 205,831 convertible preferred
@ $0 |
|
12/03/2020 |
3
| LANGER ROBERT (Director) has filed a Form 3 on Seer, Inc. |
11/19/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Gifted 56,912 shares
@ $0 |
|
10/29/2020 |
3
| LANGER ROBERT (10% Owner) has filed a Form 3 on SQZ Biotechnologies Co |
06/12/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Frequency Therapeutics, Inc.
Txns:
| Granted 14,846 options
@ $18.63, valued at
$276.6k
|
|
05/06/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns:
| Converted 668 shares
@ $0 Converted 23,057 options to buy
@ $0 |
|
05/01/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns:
| Granted 14,500 options
@ $16, valued at
$232k
|
|
04/30/2020 |
3
| LANGER ROBERT (Director) has filed a Form 3 on Lyra Therapeutics, Inc. |
04/30/2020 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Granted 18,270 options to buy
@ $46.37, valued at
$847.2k
|
|
10/17/2019 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Sold 7,500 shares
@ $8.5166, valued at
$63.9k
Exercised 7,500 options to buy
@ $0.15, valued at
$1.1k
|
|
10/02/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/17/2019 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Sold 7,500 shares
@ $14.9398, valued at
$112k
Exercised 7,500 options to buy
@ $0.15, valued at
$1.1k
|
|
06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/28/2019 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $16.27, valued at
$406.8k
|
|
04/17/2019 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Sold 7,500 shares
@ $17.5732, valued at
$131.8k
Exercised 7,500 options to buy
@ $0.15, valued at
$1.1k
|
|
01/18/2019 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Sold 7,500 shares
@ $14.5925, valued at
$109.4k
Exercised 7,500 options to buy
@ $0.15, valued at
$1.1k
|
|
12/13/2018 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Moderna, Inc.
Txns:
| Converted 4,559 shares
@ $0 Converted 4,559 preferred shares
@ $0 |
|
12/07/2018 |
3
| LANGER ROBERT (Director) has filed a Form 3 on Moderna, Inc. |
07/18/2018 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $23, valued at
$575k
|
|
07/17/2018 |
3
| LANGER ROBERT (Director) has filed a Form 3 on Rubius Therapeutics, Inc. |
06/15/2018 |
4
| LANGER ROBERT (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.
Txns:
| Granted 12,960 options to buy
@ $13.73, valued at
$177.9k
|
|
05/10/2018 |
3
| LANGER ROBERT (Director) has filed a Form 3 on Abpro Corp |
|